ImmunityBio OverviewImmunityBio Other Income Expense Net
Other Income/Expense Net for IBRX.
Quarterly Other Income/Expense
-$563.00M
↓ 763.27% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$593.11M
↓ 519.85% YoY
Trailing 12 months ending Mar 31, 2026